Waystar (WAY) Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024 summary
Event summary combining transcript, slides, and related documents.
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024 summary
2 Feb, 2026Key business highlights
Achieved 20% year-over-year revenue growth and 12% EBITDA growth in Q2, with strong free cash flow.
Completed a successful IPO and celebrated team contributions.
Operates a recurring revenue model with high visibility and durability.
Targets low double-digit revenue growth and 40% adjusted EBITDA margin.
De-levered to a 3.4x leverage ratio post-IPO, with plans to reduce further.
Product and technology differentiation
Offers a modern, multi-tenant, cloud-based platform with AI-driven automation and intuitive UI.
Addresses a $15B and growing market by simplifying provider-payer and provider-patient payment interactions.
Delivers nearly 99% first-pass claim acceptance, reducing denials and accelerating payments.
Provides in-app training, task prioritization, and knowledge retention to improve staff efficiency.
Integrates with over 200 channel partners, including major EHR vendors.
Cybersecurity and market impact
Benefited from the Change Healthcare cyberattack by onboarding over 30,000 providers on standard, multi-year agreements.
Demonstrates strong cybersecurity credentials (HITRUST, SOC 2, NIST 2.0) and rapid restoration capabilities.
Cybersecurity is now a top decision criterion for clients, driving technology replacement and platform adoption.
Multi-factor authentication and end-to-end encryption are standard.
Platform approach reduces risk compared to fragmented point solutions.
Latest events from Waystar
- Q1 2026 revenue rose 22% to $313.9M, with a 43% adjusted EBITDA margin and strong client growth.WAY
Q1 202629 Apr 2026 - Record revenue, AI innovation, and strong governance mark a transformative year.WAY
Proxy filing17 Apr 2026 - Shareholders will vote on director elections, auditor ratification, and annual say-on-pay frequency.WAY
Proxy filing17 Apr 2026 - Record FY2025 growth, 43% Q4 EBITDA margin, and strong 2026 outlook after Iodine integration.WAY
Q4 202511 Apr 2026 - AI-powered automation streamlines healthcare payments, boosting efficiency and financial outcomes.WAY
Waystar True North Client Conference3 Feb 2026 - Q2 revenue up 20% to $234.5M, 40% EBITDA margin, and improved leverage ratios.WAY
Q2 20242 Feb 2026 - Q3 revenue up 22% to $240.1M, 40% EBITDA margin, and major debt reduction post-IPO.WAY
Q3 202416 Jan 2026 - AI-driven automation and data integration fuel growth, efficiency, and client satisfaction.WAY
44th Annual J.P. Morgan Healthcare Conference12 Jan 2026 - Cloud-based healthcare payment software drives growth, efficiency, and resilience in a shifting market.WAY
7th Annual Evercore ISI HealthCONx Healthcare Conference11 Jan 2026